AI in Action E489: Jason Park, CEO at Empress Therapeutics

,  | November 27 2023 | JP Valentine

Welcome to episode 489 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Jason Park, CEO at Empress Therapeutics. Founded by Flagship Pioneering in 2020, Empress makes the discovery of effective, easy-to-take, value-driven medicines more productive with a platform that finds starting points for drugs inside the human body. The company built a proprietary product platform called Chemilogics to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society.

Empress ask big questions in pursuit of novel solutions. They operate at the intersection of the latest advances in genomics, synthetic biology and AI/ML with the expectation that these disciplines, harnessed by their ingenuity, hold the answers to finding effective medicines at a fraction of time and cost. The implications of the team’s work will be profound and the journey to get there will be exhilarating. Together, Empress are using the chemistry inside each of their employees to make medicines for all of us.

In today’s episode, Jason talks about:

His background and overview of Empress Therapeutics

An insight into Flasgship Pioneering

The impact of small molecule research in future therapeutics

How AI decodes DNA for compound predictions

How the platform created 15 drug leads in 12 months

Key team members behind their success

Their focus on swift drug lead generation from genetic data

Why to consider a career with Empress Therapeutics

To find out more about all the great work happening at Empress Therapeutics, check out the website www.empresstx.com and follow them on LinkedIn and X @Empress_Tx. You can also connect with Jason directly on LinkedIn.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

Welcome to episode 489 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Jason Park, CEO at Empress Therapeutics. Founded by Flagship Pioneering in 2020, Empress makes the discovery of effective, easy-to-take, value-driven medicines more productive with a platform that finds starting points for drugs inside the human body. The company built a proprietary product platform called Chemilogics to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society.

Empress ask big questions in pursuit of novel solutions. They operate at the intersection of the latest advances in genomics, synthetic biology and AI/ML with the expectation that these disciplines, harnessed by their ingenuity, hold the answers to finding effective medicines at a fraction of time and cost. The implications of the team’s work will be profound and the journey to get there will be exhilarating. Together, Empress are using the chemistry inside each of their employees to make medicines for all of us.

In today’s episode, Jason talks about:

His background and overview of Empress Therapeutics

An insight into Flasgship Pioneering

The impact of small molecule research in future therapeutics

How AI decodes DNA for compound predictions

How the platform created 15 drug leads in 12 months

Key team members behind their success

Their focus on swift drug lead generation from genetic data

Why to consider a career with Empress Therapeutics

To find out more about all the great work happening at Empress Therapeutics, check out the website www.empresstx.com and follow them on LinkedIn and X @Empress_Tx. You can also connect with Jason directly on LinkedIn.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

related podcasts

ServiceNow Series E147: Tej Hemantharaj, Director – Technical Lead at Fujitsu North America

 Welcome to episode 147 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E502: Brian Hart, CTO at Covera Health

 Welcome to episode 502 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

ServiceNow Series E146: Florian Wallrodt, Senior Consultant and Product Line Lead ITSM at agineo

 Welcome to episode 146 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More